Toxyloxanthone BCAS# 50875-24-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 50875-24-6 | SDF | Download SDF |
PubChem ID | 14886044 | Appearance | Yellow powder |
Formula | C18H14O6 | M.Wt | 326.3 |
Type of Compound | Xanthones | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,9,11-trihydroxy-3,3-dimethylpyrano[3,2-a]xanthen-12-one | ||
SMILES | CC1(C=CC2=C(O1)C(=CC3=C2C(=O)C4=C(C=C(C=C4O3)O)O)O)C | ||
Standard InChIKey | MFKYNKVEQUTJEH-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H14O6/c1-18(2)4-3-9-14-13(7-11(21)17(9)24-18)23-12-6-8(19)5-10(20)15(12)16(14)22/h3-7,19-21H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Toxyloxanthone B Dilution Calculator
Toxyloxanthone B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.0647 mL | 15.3233 mL | 30.6466 mL | 61.2933 mL | 76.6166 mL |
5 mM | 0.6129 mL | 3.0647 mL | 6.1293 mL | 12.2587 mL | 15.3233 mL |
10 mM | 0.3065 mL | 1.5323 mL | 3.0647 mL | 6.1293 mL | 7.6617 mL |
50 mM | 0.0613 mL | 0.3065 mL | 0.6129 mL | 1.2259 mL | 1.5323 mL |
100 mM | 0.0306 mL | 0.1532 mL | 0.3065 mL | 0.6129 mL | 0.7662 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- V1 iridoid
Catalog No.:BCN0455
CAS No.:87441-71-2
- Acronyculatin Q
Catalog No.:BCN0454
CAS No.:2287183-54-2
- Mecambridine
Catalog No.:BCN0453
CAS No.:31098-60-9
- Acropyrone
Catalog No.:BCN0452
CAS No.:1381875-14-4
- Furanofukinin
Catalog No.:BCN0451
CAS No.:34335-93-8
- 6-O-Ethyltetradymodiol
Catalog No.:BCN0450
CAS No.:1028530-06-4
- 6β-Ethoxyfuranoeremophilane
Catalog No.:BCN0449
CAS No.:82462-36-0
- Phenylacetylglycine
Catalog No.:BCN0448
CAS No.:500-98-1
- N1-Methyl-2-pyridone-5-carboxamide
Catalog No.:BCN0447
CAS No.:701-44-0
- Petasalbin
Catalog No.:BCN0446
CAS No.:4176-11-8
- β-D-Allose
Catalog No.:BCN0445
CAS No.:2595-97-3
- Alaschanioside A
Catalog No.:BCN0444
CAS No.:157446-63-4
- Bis(2-ethylhexyl) terephthalate
Catalog No.:BCN0457
CAS No.:6422-86-2
- (+/-)-N-methylcoclaurine
Catalog No.:BCN0458
CAS No.:1472-62-4
- 5-exo-Hydroxyborneol
Catalog No.:BCN0459
CAS No.:32751-73-8
- 3,8-Di-O-methylellagic acid 2-O-(5'-O-acetyl)arabinofuranoside
Catalog No.:BCN0460
CAS No.:365540-09-6
- 4,5-Dioxodehydroasimilobine
Catalog No.:BCN0461
CAS No.:82644-81-3
- 2,4-Dihydroxy-6-methoxy-3,5-diprenylacetophenone
Catalog No.:BCN0462
CAS No.:123999-38-2
- Alpinigenine
Catalog No.:BCN0463
CAS No.:14028-91-2
- Tabernaecorymbosine A
Catalog No.:BCN0464
CAS No.:1262306-81-9
- Flindulatin
Catalog No.:BCN0465
CAS No.:521-44-8
- (±)-Cleroindicin F
Catalog No.:BCN0466
CAS No.:94535-01-0
- p-O-Farnesylcoumaric acid
Catalog No.:BCN0467
CAS No.:939769-47-8
- 6,4'-Dihydroxy-5,7-dimethoxyflavanone
Catalog No.:BCN0468
CAS No.:6951-57-1
[Chemical Constituents of Ethyl Acetate Fraction from Hypericum ascyron].[Pubmed:30080367]
Zhong Yao Cai. 2016 Feb;39(2):322-5.
Objective: To study the chemical consituents of Hypericum ascyron. Methods: The constituents were isolated and purified by chromatography on silica gel; the structure of the compound was determined by MS and NMR spectral analysis. Results: On the basis of spectroscopic analysis and comparison with the reported data, they were identified as hyperoside( 1),hypercalin B( 2),hypercalin C( 3),1,7-dihydroxyxanthone( 4),2,3-dimethoxyxanthone( 5),1-hydroxy-7-methoxyxanthone( 6),rutin( 7),kaempferol( 8),Toxyloxanthone B( 9),quercetin( 10),quercitrin( 11),beta-daucosterol( 12) and beta-sitosterol( 13). Conclusion: Compounds 2,3,6 and 9 are obtained from this plant for the first time.
Xanthones from roots, hairy roots and cell suspension cultures of selected Hypericum species and their antifungal activity against Candida albicans.[Pubmed:26194328]
Plant Cell Rep. 2015 Nov;34(11):1953-62.
KEY MESSAGE: Highest xanthone contents were found in Hypericum pulchrum and H. annulatum untransformed roots. The best anti- Candida activity was obtained for hairy roots extracts of H. tetrapterum clone 2 ATCC 15834. Extracts of root cultures, hairy roots and cell suspensions of selected Hypericum spp. were screened for the presence of xanthones and tested for their antifungal activity against Candida albicans strain ATCC 10231. At least one of the following xanthones, 5-methoxy-2-deprenylrheediaxanthone; 1,3,6,7-tetrahydroxyxanthone; 1,3,5,6-tetrahydroxyxanthone; paxanthone; kielcorin or mangiferin was identified in methanolic extracts of the untransformed root cultures. The highest total xanthone content, with five xanthones, was found in untransformed H. pulchrum and H. annulatum root cultures. Hairy roots and the controls of H. tetrapterum contained 1,7-dihydroxyxanthone, while hairy root cultures and the corresponding controls of H. tomentosum contained Toxyloxanthone B, 1,3,6,7- and 1,3,5,6-tetrahydroxyxanthone. Two xanthones, cadensin G and paxanthone, were identified in cell suspension cultures of H. perforatum. Their content increased about two-fold following elicitation with salicylic acid. The anti-Candida activity of the obtained extracts ranged from MIC 64 to >256 microg ml(-1). Among the extracts of Hypericum untransformed roots, the best antifungal activity was obtained for extracts of H. annulatum grown under CD conditions. Extracts of hairy roots clones A4 and 7 ATCC15834 of H. tomentosum and clone 2 ATCC15834 of H. tetrapterum displayed inhibition of 90% of Candida growth with 256 mug ml(-1). Extracts from chitosan-elicitated cells did not show antifungal activity.
Phenolic constituents from the leaves of Cratoxylum formosum ssp. pruniflorum.[Pubmed:24534445]
Fitoterapia. 2014 Apr;94:114-9.
One (formosumone A, 1) new and fifteen (2-16) known phenolic compounds were isolated from the leaves of Cratoxylum formosum ssp. pruniflorumm, a substitute for the popular bitter nail tea ("Kuding Tea") generally used in Southeast Asia. Their structures were determined by extensive spectroscopic analysis and by comparison with literature data. Compound 1 possesses a rare scaffold of a flavanone coupled with a phloroglucinol moiety, representing the first example of such a scaffold from the Clusiaceae family. Among the isolates, Toxyloxanthone B (11) and vismione D (12) were found to show remarkable anti-neuroinflammatory effects by inhibiting nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated murine BV-2 microglial cells. Additionally, Toxyloxanthone B (11) exhibited significant neuroprotective effect against beta-amyloid(25-35) (Abeta(25-35))-induced cell viability decrease in SH-SY5Y neuroblastoma cells.